H van der Molen Selected Research

Monoclonal Antibodies

5/2001

The epithelial glycoprotein 2 (EGP-2) promoter-driven epithelial-specific expression of EGP-2 in transgenic mice: a new model to study carcinoma-directed immunotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

H van der Molen Research Topics

Disease

1	Body Weight (Weight, Body) 02/2015
1	Obesity 02/2015
1	Thinness 02/2015
1	Carcinoma (Carcinomatosis) 05/2001
1	Neoplasms (Cancer) 05/2001

Drug/Important Bio-Agent (IBA)

1	ChromatinIBA 02/2015
1	Insulin (Novolin)FDA Link 02/2015
1	Glucose (Dextrose)FDA LinkGeneric 02/2015
1	Glycoproteins (Glycoprotein)IBA 05/2001
1	Monoclonal AntibodiesIBA 05/2001
1	AntigensIBA 05/2001
1	Epithelial Cell Adhesion MoleculeIBA 05/2001

Therapy/Procedure

1	Therapeutics 02/2015
1	Immunotherapy 05/2001